Trials / Conditions / Neuromuscular Blockade, Residual

Neuromuscular Blockade, Residual

5 registered clinical trials studyying Neuromuscular Blockade, Residual.

Status	Trial	Sponsor	Phase
Completed	Incidence of Postoperative Residual Curarization NCT06193213	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	—
Completed	Neostigmine/Glyco-pyrrolate 50 Mikrogram/kg or Sugammadex 2 mg/kg for Reversal of Neuromuscular Blockade in El NCT06228092	Matias Vested	Phase 4
Active Not Recruiting	Does Electromyography Improve Precision and Reliability of Neuromuscular Monitoring in Paediatric Patients NCT06062290	University Hospital Ulm	—
Unknown	Three Different Doses of Neostigmine on the Reversal of Cisatracurium-induced Moderate Neuromuscular Blockade NCT05037006	Pontificia Universidade Catolica de Sao Paulo	Phase 4
Completed	A Comparison of Rocuronium 0.3 mg/kg, and 0.9 mg/kg for Induction of Anesthesia in Elderly Patients. NCT04512313	Rigshospitalet, Denmark	N/A